CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Conditions:   Thyroid Neoplasms;   Poorly Differentiated and Undifferentiated Thyroid Cancer;   Differentiated Thyroid Cancer
Intervention:   Drug: CUDC-907
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting - verified December 2016

http://ift.tt/2iaGa3Y